Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06536946
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-31
Brief Title:
B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Expression of B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Examine the role of B-catenin in differentiation of cutaneous squamous cell carcinoma from other lesions that may be similar to it
Detailed Description:
Skin cancer is one of the most common form of cancer worldwide Cutaneous squamous cell carcinoma is one of most common skin tumers that caused by many factors as ultra violet ionizing radiation and others It was an advanced spectrum ranging from actinic keratosis to invasive and metastatic squmous cell carcinoma Correct identification of cutaneous squamous cell carcinoma is a challenge as it has both clinically and histopathologically mimickers
So the aim of this study is to identify the expression of B-catenin in cutaneous Squamous cell carcinoma and its mimickers
So the aim of this study is to identify the expression of B-catenin in cutaneous Squamous cell carcinoma and its mimickers
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None